SCHEMBL6589537

SCHEMBL6589537

Fc1cccc(C2=CCN(CCc3ccc4ccncc4c3)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.51
PARP1 P09874 3/20 0.50
HTR1A P08908 4/20 0.41
DRD2 P14416 3/20 0.41
DRD4 P21917 3/20 0.41
DRD3 P35462 3/20 0.41
SLC6A3 Q01959 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6587721 0.96 SIGMAR1 (0.51) SIGMAR1PARP1HTR1ADRD2DRD4
SCHEMBL6592540 0.90 SIGMAR1 (0.58) SIGMAR1PARP1HTR1ADRD2DRD4
Ssr-150106 SCHEMBL1385047 0.87 SIGMAR1 (0.48) SIGMAR1PARP1DRD2DRD4DRD3
Ssr-150106 SCHEMBL29393331 0.87 SIGMAR1 (0.48) SIGMAR1PARP1DRD2DRD4DRD3
SCHEMBL6590514 0.83 SIGMAR1 (0.48) SIGMAR1PARP1DRD2DRD4DRD3
SCHEMBL6587088 0.83 SIGMAR1 (0.52) SIGMAR1PARP1DRD2DRD4DRD3
SCHEMBL14277663 0.82 PARP1 (0.48) SIGMAR1PARP1HTR1ASLC6A3HTR7
SCHEMBL6608875 0.82 PARP1 (0.50) SIGMAR1PARP1HTR1ADRD2DRD4
SCHEMBL6594692 0.82 PARP1 (0.50) SIGMAR1PARP1HTR1ADRD2DRD4
SCHEMBL14277638 0.82 PARP1 (0.47) SIGMAR1PARP1HTR1ASLC6A3HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226137-B1 PHENYL- AND PYRIDYL-TETRAHYDRO-PYRIDINES HAVING TNF INHIBITING ACTIVITY SANOFI SYNTHELABO (FR) 2004-07-21 EP disclosed
CN-1158276-C Phenyl-and pyridyl-tetrahydropyridines with TNF inhibiting activity ʥŵ��-�ϳ�ʵ���ҹ�˾ 2004-07-21 CN disclosed
US-6509351-B1 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation SANOFI-SYNTELABO (FR) 2003-01-21 US disclosed